By David Rauf
Mannatech and Reliv both report losses in fourth quarter.
Note: We listen in on the public company earnings calls and read the transcripts so you don’t have to. Check back each quarter for our review with insights and takeaways for your own business.
This report includes an update on the earnings calls from Mannatech and Reliv, both of which had revenue losses for the year-end quarter.
Please see the March and April issues for reports from the other public direct selling companies.
Mannatech Inc.
The Flower Mound, Texas-based nutritional supplement maker Mannatech says it successfully launched several new products in 2018—including a global expansion of its signature product line—but reported flat sales figures for 2018. Revenue also decreased during Q4. And the company’s stock dropped by 11 percent to $17.04 in March after reporting earnings, but rebounded to $18.00 by the second week of April.
Nu Skin China has offered deep condolences to the family of one of its sales representatives, who recently died.
The hedge fund group Raymond James Financial Services Advisors Inc. bought 28,698 shares of Youngevity stock in the fourth quarter, with an approximate value of $164,000.
Natura & Co is adding a “bankarization” element to the list of perks it offers its beauty consultants.
The Wall Street Journal reported that Natura & Co and Avon are discussing a possible acquisition. After the news was announced on WSJ, Bloomberg, and many other websites, the stock price for Avon Products Inc. increased by 13 percent. The possible merger would potentially give more than 1 million Brazilian beauty consultants access to Avon products.
Health and wellness company Reliv is experiencing a decline in sales.
Youngevity is expected to begin shipping its first CBD Isolate Powder this month.
Avon is partnering with the new British Beauty Council to help support and represent the beauty industry in the U.K.
Newer Posts